HedgeChatter

  • Home /
  • Tag Archives

IPCI

Intellipharmaceutics Announces Results of Initial Phase I Clinical Trial of Controlled-Release Pregabalin and Product Updates

[at noodls] – TORONTO, Nov. 27, 2012 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and … moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboard […]

November 27, 2012 Bystocknews , Comments Off on Intellipharmaceutics Announces Results of Initial Phase I Clinical Trial of Controlled-Release Pregabalin and Product Updates read more

Intellipharmaceutics to Present at the 24th Annual Piper Jaffray Healthcare Conference

[at noodls] – TORONTO, Nov. 21, 2012 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and … moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboard […]

November 21, 2012 Bystocknews , Comments Off on Intellipharmaceutics to Present at the 24th Annual Piper Jaffray Healthcare Conference read more